You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ELN

Showing 26 - 50 of 228
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Berlin, Germany
  • +9 more
Jan 13, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (8-Chloroadenosine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

AML, Adult, Minimal Residual Disease Trial (MRD assessment)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • MRD assessment
  • (no location specified)
Oct 13, 2023

Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

Not yet recruiting
  • Acute Myeloid Leukemia
  • Tagraxofusp (Cycles 1-2)
  • +2 more
  • (no location specified)
Jun 28, 2022

Acute Myeloid Leukemia Trial in France (Dexamethasone)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Angers, France
  • +24 more
Jul 26, 2022

Williams Syndrome and Supravalvular Aortic Stenosis DNA and

Recruiting
  • Williams Syndrome
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Acute Myeloid Leukemia Trial in Italy (Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Bergamo, Italy
    • +21 more
    Jan 9, 2023

    Acute Myeloid Leukemia, Adult Trial in Houston (ADI-PEG 20)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • ADI-PEG 20
    • Houston, Texas
      MD Anderson Cancer Center
    Sep 29, 2022

    Myeloproliferative Tumors Trial (INCA033989)

    Not yet recruiting
    • Myeloproliferative Neoplasms
    • (no location specified)
    Sep 11, 2023

    Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Scottsdale, Arizona
    • +43 more
    Nov 17, 2022

    Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia

    Not yet recruiting
    • Acute Myeloblastic Leukemia
      • (no location specified)
      Aug 10, 2022

      Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

      Recruiting
      • Chronic Myeloid Leukemia
      • Birmingham, Alabama
      • +25 more
      Mar 4, 2022

      Non-Hodgkin Lymphoma (NHL), Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial in Worldwide (VOB560, MIK665)

      Recruiting
      • Non-Hodgkin Lymphoma (NHL)
      • +2 more
      • Gent, Belgium
      • +9 more
      Mar 18, 2022

      Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Nov 4, 2022

      Healthy Trial (HC-ER 20 mg capsule (fasted), HC-ER 20 mg capsule (fed))

      Completed
      • Healthy
      • HC-ER 20 mg capsule (fasted)
      • HC-ER 20 mg capsule (fed)
      • (no location specified)
      Nov 8, 2022

      MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • Aachen, NRW, Germany
      • +2 more
      Mar 29, 2023

      Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

      Recruiting
      • Myeloproliferative Neoplasms
      • Birmingham, Alabama
      • +16 more
      Jan 27, 2023

      Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Denver, Colorado
      • +8 more
      May 19, 2022

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

      Recruiting
      • Primary Myelofibrosis
      • +4 more
      • New York, New York
        Ruttenberg Treatment Center
      Jul 18, 2022

      Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Nantes, France
        CHU de Nantes
      Jan 24, 2023

      Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia Trial in United States

      Active, not recruiting
      • Recurrent Acute Myeloid Leukemia
      • +3 more
      • Tampa, Florida
      • +5 more
      Nov 18, 2022

      Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Lyon, France
        Centre Léon Bérard
      Nov 30, 2023

      Real World Outcomes Using Novel Agents for AML in the UK

      Not yet recruiting
      • Acute Myeloid Leukemia
      • London, United Kingdom
        Guy's and St Thomas' NHS Foundation Trust
      Mar 28, 2022

      AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)

      Not yet recruiting
      • AML, Adult
      • Hangzhou, China
      • +3 more
      Feb 12, 2023